Dioscorea Oppositifolia (wild Yam) Root US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005174
Compound index — D
597 substances begin with D. 2 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 197 of them, Dioscorea Oppositifolia… – Dysprosium.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Dioscorea panthaica CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005175
Dioscorea polystachya CA-NHP Not yet graded
CA licensed ingredient
Market presence23 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005176
Dioscorea rotundata EU-NOVEL Not yet graded
Not novel in food
Parts in scopeRoots (tuber)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005177
Dioscorea spongiosa CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005178
Dioscorea villosa CA-NHP Not yet graded
CA licensed ingredient
Market presence188 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005179
Dioscorea Villosa Root US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Amino Acid [EPC]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005180
Dioscorea Villosa Tuber US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence56 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005181
Dioscoreinum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005182
Diosmectite EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005183
Diosmin CA-NHPEU-CLAIMEU-NOVELUS-DRUG Not yet graded
Not novel in supplementsEU claims 0 authorised / 1 refusedCA licensed ingredientUS: unapproved drug other
Class as recordedAscorbic Acid [CS]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Vitamin C [EPC]
Market presence1 US product listings · 3 Canadian licensed products
Parts in scopeSubstance
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps maintain a good venous blood circulation. Supports a normal venous function. Helps maintain healthy venous circulation in the legs. Protects veins from inflammatory reactions. Supports the strength of blood vessels.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-005184
Diospyros kaki CA-NHP Not yet graded
CA licensed ingredient
Market presence26 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005185
Diospyros virginiana CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005186
Dioxaphetyl butyrate US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005187
Dioxybenzone US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005188
Dipalmitoylphosphatidylcholine EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005189
Dipeptide Diaminobutyroyl Benzylamide Diacetate US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005190
DIPEPTIDE-2 US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005191
Dipeptidyl aminopeptidase IV CA-NHP Not yet graded
CA licensed ingredient
Market presence104 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005192
Dipeptidyl-peptidase IV CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005193
Diphasiastrum complanatum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005194
Diphemanil Methylsulfate US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005195
Diphencyprone US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005196
Diphenhydramine US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic alpha1-Agonists [MoA]; Anti-Inflammatory Agents; Copper Absorption Inhibitor [EPC]; Cyclooxygenase Inhibitors [MoA]
Earliest US approval1946
Market presence1,219 US product listings · 109 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005197
Diphenhydramine HCL US-DRUG Not yet graded
US: anda
Class as recordedCopper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
Market presence15 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005198
Diphenidol Hydrochloride US-DRUG Not yet graded
Earliest US approval1967
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005199
Diphenoxylate Diphenoxylate preparations 2.5 mg/25 ug AtSO4 V Y Lomotil; Logen US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005201
Diphenoxylate Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAnticholinergic [EPC]; Antidiarrheal [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]
Earliest US approval1960
Market presence33 US product listings · 39 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005200
Diphenylpyraline Hydrochloride US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005202
Diphenyltrichloroethane US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Inactivated Clostridium Tetani Vaccine [EPC]; Inactivated [CS]; Tetanus Toxoid [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005203
Diphosphoric acid tin(2+) salt (1:2) CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005205
Diphosphoric acid, tetrasodium salt CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005204
Diphtheria toxoid EU-MED Not yet graded
EU medicine: Authorised, Lapsed
Class as recordedJ07AJ; J07CA; J07CA05; J07CA09
Market presence10 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005206
Diphtherial Respiratory Pseudomembrane Human US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005207
Diphtherinum CA-NHP Not yet graded
CA licensed ingredient
Market presence16 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005208
Dipipanone US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesDipipan; phenylpiperone HCl; Diconal; Wellconal
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005209
Dipivefrin Hydrochloride US-DRUG Not yet graded
Earliest US approval1980
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005210
Diplacus Aurantiacus Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005211
Diplotaxis tenuifolia L. EU-NOVEL Not yet graded
Not novel in food
Parts in scopeLeaves and stems; Seeds
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005212
Dipotassium Glycyrrhizate US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAdenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005214
Dipotassium phosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005213
Dipsacus asper CA-NHP Not yet graded
CA licensed ingredient
Market presence163 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005215
Dipsacus asperoides CA-NHP Not yet graded
CA licensed ingredient
Market presence21 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005216
Dipsacus Fullonum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005217
Dipsacus japonicus CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005218
Dipteryx alata EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSeeds
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005219
Dipteryx odorata (Aubl.) Forsyth f. EU-NOVEL Not yet graded
Not novel in food
Parts in scopeseed
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005220
Diptherinum CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005221
Dipyridamole US-DRUG Not yet graded
US: anda
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]
Earliest US approval1961
Market presence31 US product listings · 38 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005222
Dipyrone US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005223
Dirithromycin US-DRUG Not yet graded
Earliest US approval1995
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005224
dirlotapide EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQA08AB91
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005225
Diselenium Dichloride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005227
Disodium dihydrogen pyrophosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005229
Disodium hydrogen phosphate heptahydrate CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005230
Disodium phosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005228
Disodium phosphorofluoridate CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005231
Disodium Pyrophosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005232
Disodium tetraborate decahydrate CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005233
Disopyramide Phosphate US-DRUG Not yet graded
US: anda
Class as recordedAntiarrhythmic [EPC]
Earliest US approval1977
Market presence13 US product listings · 20 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005234
Distearoylphosphatidylcholine, DL- US-DRUG Not yet graded
US: nda
Class as recordedContrast Agent for Ultrasound Imaging [EPC]; Ultrasound Contrast Activity [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005235
Distichlis Spicata Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005236
Distictis rigescens EU-NOVEL Not yet graded
Disulfiram US-DRUG Not yet graded
US: anda
Class as recordedAcetyl Aldehyde Dehydrogenase Inhibitors [MoA]; Aldehyde Dehydrogenase Inhibitor [EPC]
Earliest US approval1951
Market presence12 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005238
Divalproex Sodium US-DRUG Not yet graded
US: anda
Class as recordedAnti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
Earliest US approval1983
Market presence191 US product listings · 44 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005239
DL-2-Amino-4-(methylthio)-butyric acid CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000328
DL-2-Hydroxy-2-phenylacetic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000350
DL-alpha-Lipoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence1,949 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-001241
DL-Methionine and L-cystine sulphur amino acids EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Increase hair and nail resistance and promote their growth” | Non-authorised | Art.13(1) | EFSA opinion |
| “Increase hair and nail resistance and promote their growth” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009528
DM4 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005240
DMAE (dimethylaminoethanol) and its salts EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeSubstance
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005241
DNA CA-NHP Not yet graded
CA licensed ingredient
Market presence37 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005242
DNA-Directed RNA Polymerase Subunit Beta (m. Tuberculosis) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Dietary [EXT]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005243
Dnoc US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005244
Dobutamine Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic beta-Agonists [MoA]; beta-Adrenergic Agonist [EPC]
Earliest US approval1978
Market presence18 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005245
Docetaxel EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedL01CD02; Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
Earliest US approval1996
Market presence87 US product listings · 31 FDA applications · 9 EU medicines
Etalyn identifierETA-C-005246
Dock CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005247
Doconazole US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005248
Doconexent US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005249
Docosahexaenoic Acid CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 6 authorised / 3 refusedCA licensed ingredientUS: unapproved drug other
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Folate Analog [EPC]; Folic Acid [CS]
Market presence1 US product listings · 6 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Docosahexaenoic acid (DHA) intake contributes to the normal visual development of infants up to 12 months of age.” | Authorised | Art.14(1)(b) | EFSA opinion |
| “Docosahexaenoic acid (DHA) maternal intake contributes to the normal development of the eye of the foetus and breastfed infants.” | Authorised | Art.14(1)(b) | EFSA opinion |
| “DHA contributes to maintenance of normal brain function” | Authorised | Art.13(1) | EFSA opinion |
| “DHA contributes to the maintenance of normal vision” | Authorised | Art.13(1) | EFSA opinion |
| “Docosahexaenoic acid (DHA) maternal intake contributes to the normal brain development of the foetus and breastfed infants.” | Authorised | Art.14(1)(b) | EFSA opinion |
| “Contributes to good quality of cholesterol particles. Contributes to good quality cholesterol.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps maintain sperm motility helps maintain a healthy male reproductive system” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps to control body weight when combined with a healthy diet and exercise. Fits in a weight maintainance programme. Contributes to the reduction of body fat. Helps to control fat metabolism.” | Non-authorised | Art.13(1) | EFSA opinion |
| “DHA contributes to the maintenance of normal blood triglyceride levels” | Authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-005250
Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Docosahexaenoic acid (DHA) and arachidonic acid (ARA) contribute to the optimal brain development of infants and young children” | Non-authorised | Art.14(1)(b) | EFSA opinion |
| “DHA & ARA support neural development of the brain and eyes.” | Non-authorised | Art.14(1)(b) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005251
Docosahexaenoic acid and Eicosapentaenoic acid (DHA/EPA) EU-CLAIM Not yet graded
EU claims 2 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “DHA and EPA contribute to the maintenance of normal blood pressure” | Authorised | Art.13(1) | EFSA opinion |
| “DHA and EPA contribute to the maintenance of normal blood triglyceride levels” | Authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005252
Docosanol US-DRUG Not yet graded
US: anda
Earliest US approval2000
Market presence80 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005253
Docusate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]
Market presence380 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005254
dodecafluoropentane EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedV08DA
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005255
Dodecahydroxycyclohexane Dihydrate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005256
Dodecanoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005257
Dodecanoic Acid, 2,3-Dihydroxypropyl Ester CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005258
Dolasetron Mesylate US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1997
Market presence3 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005260
Dolichos pruriens CA-NHP Not yet graded
CA licensed ingredient
Market presence18 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005262
Dolichos purpureus EU-NOVEL Not yet graded
Dolichovespula Arenaria Venom Protein US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005264
Dolichovespula Maculata Venom Protein US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005265
Dolomiaea soulei CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005266
Dolomiaea souliei CA-NHP Not yet graded
CA licensed ingredient
Market presence98 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005267
Dolomite CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005268
Dolutegravir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 1A1 Inhibitors [MoA]; HIV Integrase Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Earliest US approval2013
Market presence28 US product listings · 29 FDA applications · 3 EU medicines
Etalyn identifierETA-C-005269
Dolutegravir And Lamivudine US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005270
Dolutegravir Lamivudine Tenofovir Alafenamide US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005272
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005271
Domiphen Bromide US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005273
Domperidone US-DRUG Not yet graded
US: bulk ingredient
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005274
Donanemab-Azbt US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005276
Donepezil EU-MEDUS-DRUG Not yet graded
EU medicine: RefusedUS: anda
Class as recordedCholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]; N-methyl-D-aspartate Receptor Antagonist [EPC]; N06D
Earliest US approval1996
Market presence120 US product listings · 58 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005277
Donislecel US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005279
Donor Human Stool US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005280
Donor Human Stool Spores (ethanol Treated) US-DRUG Not yet graded
US: bla
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005281
Donor:hydrogen-peroxide oxidoreductase CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005282
Dopamine CA-NHPEU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedCA licensed ingredientUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Amino Acid [EPC]
Earliest US approval1974
Market presence85 US product listings · 37 FDA applications · 1 EU medicines · 5 Canadian licensed products
Etalyn identifierETA-C-005284
Doramectin US-DRUG Not yet graded
US: bulk ingredient
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005285
Doravirine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; J05AG06
Earliest US approval2018
Market presence13 US product listings · 3 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005286
Dordaviprone US-DRUG Not yet graded
US: nda
Earliest US approval2025
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005287
Dornase Alfa US-DRUG Not yet graded
US: bla
Class as recordedDecreased Respiratory Secretion Viscosity [PE]; Deoxyribonuclease I [CS]; Recombinant Human Deoxyribonuclease 1 [EPC]; Recombinant Proteins [CS]
Earliest US approval1993
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005289
dorocubicel EU-MED Not yet graded
EU medicine: Authorised
Class as recordedB05AX04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005290
Doryphora decemlineata CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005291
Dorzolamide Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic beta-Antagonists [MoA]; Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; beta-Adrenergic Blocker [EPC]
Earliest US approval1994
Market presence52 US product listings · 37 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005292
Dostarlimab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01FF07; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
Market presence2 US product listings · 1 EU medicines
Etalyn identifierETA-C-005293
Dostarlimab-Gxly US-DRUG Not yet graded
Earliest US approval2021
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005294
Dothiepin Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005295
Doxacurium Chloride US-DRUG Not yet graded
Earliest US approval1991
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005296
Doxapram Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Class as recordedIncreased Medullary Respiratory Drive [PE]; Respiratory Stimulant [EPC]
Earliest US approval1965
Market presence3 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005297
Doxazosin Mesylate US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
Earliest US approval1990
Market presence145 US product listings · 21 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005298
Doxepin Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedTricyclic Antidepressant [EPC]
Earliest US approval1969
Market presence219 US product listings · 87 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005300
Doxercalciferol US-DRUG Not yet graded
US: anda
Class as recordedErgocalciferols [CS]; Vitamin D2 Analog [EPC]
Earliest US approval1999
Market presence22 US product listings · 19 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005301
Doxofylline US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005302
Doxorubicin EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedAnthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; L01DB; L01DB01
Earliest US approval1974
Market presence72 US product listings · 30 FDA applications · 7 EU medicines
Etalyn identifierETA-C-005303
Doxycycline EU-MEDUS-DRUG Not yet graded
Doxylamine Succinate US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]; Analogs/Derivatives [Chemical/Ingredient]; Anti-Inflammatory Agents
Earliest US approval1948
Market presence508 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005306
Draba Verna Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Inactivated Poliovirus Vaccine [EPC]; Inactivated [CS]; Live
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005307
Dried Aluminum Hydroxide gel CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005308
Dried cranberry juice CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005309
Dried egg powder CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005310
Dried Ferrous sulfate powder CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005311
Dried plums of 'prune' cultivars (Prunus domestica L.) EU-CLAIM Not yet graded
EU claims 1 authorised / 0 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Dried plums/prunes contribute to normal bowel function” | Authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005312
Dried yeast CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005313
Drimia maritima CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005314
Drimia Maritima Bulb US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005315
Drimia Maritima Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005316
Dromaius novaehollandiae CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005317
Dromostanolone Propionate US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005318
Dronabinol US-DRUG Not yet graded
US: anda
Class as recordedCannabinoid [EPC]; Cannabinoids [CS]
Earliest US approval1985
Market presence29 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005319
Dronabinol (synthetic) in sesame oil in soft gelatin capsule as approved by FDA approved by FDA US-CSA Not yet graded
CSA Schedule III
also: Dronabinol in sesame oil in soft gelatin capsule as approved by FDA approved by FDA
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesMarinol; synthetic THC in sesame oil/soft gelatin as
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005321
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration US-CSA Not yet graded
CSA Schedule II
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesSyndros
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005320
Dronedarone EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bulk ingredient
Class as recordedAntiarrhythmic [EPC]; C01BD07; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]
Earliest US approval2009
Market presence11 US product listings · 8 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005322
Droperidol US-DRUG Not yet graded
US: anda
Class as recordedDopamine D2 Antagonists [MoA]; Dopamine-2 Receptor Antagonist [EPC]
Earliest US approval1970
Market presence4 US product listings · 26 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005323
Drosera CA-NHP Not yet graded
CA licensed ingredient
Market presence64 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005324
Drosera Anglica US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Animal Fur [CS]; Ascorbic Acid [CS]; Bee Venoms [CS]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005325
Drosera Intermedia US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005326
Drosera Rotundifolia CA-NHPUS-DRUG Not yet graded
Drosera Rotundifolia Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005328
Drosera Rotundifolia Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]
Market presence37 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005329
Drospirenone EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedEstradiol Congeners [CS]; Estrogen Receptor Agonists [MoA]; Estrogen [EPC]; G03
Earliest US approval2001
Market presence16 US product listings · 41 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005330
Drostanolone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesDrolban; Masterid; Permastril
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005331
Drotebanol US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesMetebanyl; oxymethebanol
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005332
drotrecogin alfa (activated) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedB01AD10
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005333
Droxidopa US-DRUG Not yet graded
US: anda
Class as recordedCatecholamines [CS]; Increased Blood Pressure [PE]
Earliest US approval2014
Market presence53 US product listings · 17 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005334
dry aqueous extract of paullinia cupana seed EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005335
dry extract from birch bark (DER 5-10 : 1) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedD03AX13
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005336
dry hydroethanolic extract of theobroma cacao seed EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005337
Dry isoflavones soya extract EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Act on hair bulb in order to support hair growth. Prevent hair from premature ageing via their antioxidant properties and on the microcirculation” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005338
Drynaria fortunei CA-NHP Not yet graded
CA licensed ingredient
Market presence98 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005339
Dryobalanops aromatica CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005340
Dryopteris crassirhizoma CA-NHP Not yet graded
CA licensed ingredient
Market presence21 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005341
Dryopteris filix-mas CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005342
Dryopteris Filix-MAS Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005343
Duboisia myoporoides CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005344
Duboisia Myoporoides Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCalculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005345
Duchesnea indica CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005346
Duck US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005347
Dulaglutide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedA10BJ05; GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
Earliest US approval2014
Market presence21 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005348
Dulcamara CA-NHP Not yet graded
CA licensed ingredient
Market presence97 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005349
Dulcamara-flos CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005350
Duloxetine EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedN06AX21; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
Earliest US approval2004
Market presence242 US product listings · 32 FDA applications · 8 EU medicines
Etalyn identifierETA-C-005351
Dunaliella salina CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Avron 1982; Protococcus salinus Dunal 1837, Haemotococcus salinus Dunal 1837, Monas dunalii Joly 1840, Diselmis dunalii(Joly) Dujardin 1841, Chlamydomonas dunalii (Joly) F.J.Cohn 1865,Dunaliella bardawil Ben-Amotz &
Market presence21 Canadian licensed products
Parts in scopeWhole; beta-carotene extract
Etalyn identifierETA-C-005352
Dupilumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; D11AH05; Interleukin 4 Receptor alpha Antagonists [MoA]; Interleukin-4 Receptor alpha Antagonist [EPC]
Earliest US approval2017
Market presence8 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005353
Durlobactam Sodium US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2023
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005355
Durvalumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; L01XC28; Monoclonal [CS]; Programmed Death Ligand-1 Antagonists [MoA]
Earliest US approval2017
Market presence10 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005356
Durvillaea antarctica EU-NOVEL Not yet graded
Not novel in supplements
also: Fucus antarcticus Chamisso 1822
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005357
Dutasteride US-DRUG Not yet graded
US: anda
Class as recorded5-alpha Reductase Inhibitor [EPC]; 5-alpha Reductase Inhibitors [MoA]; Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
Earliest US approval2001
Market presence54 US product listings · 25 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005358
Dyclonine Hydrochloride US-DRUG Not yet graded
US: anda
Earliest US approval2018
Market presence29 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005360
Dydrogesterone US-DRUG Not yet graded
US: bulk ingredient
Market presence7 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005361
Dyphylline US-DRUG Not yet graded
Earliest US approval1951
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005362
Dysphania Ambrosioides CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence19 US product listings · 5 Canadian licensed products
Etalyn identifierETA-C-005363
Dysphania Ambrosioides Pollen US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Animal Fur [CS]; Antigens; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005364
Dysphania Ambrosioides Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005365
Dysphania Botrys Pollen US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005366
Dysprosium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ascorbic Acid [CS]
Market presence25 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005367